Literature DB >> 33455601

The neuroscience of diabetic retinopathy.

David A Antonetti1,2.   

Abstract

Diabetic retinopathy remains a leading cause of blindness despite recent advance in therapies. Traditionally, this complication of diabetes was viewed predominantly as a microvascular disease but research has pointed to alterations in ganglion cells, glia, microglia, and photoreceptors as well, often occurring without obvious vascular damage. In neural tissue, the microvasculature and neural tissue form an intimate relationship with the neural tissue providing signaling cues for the vessels to form a distinct barrier that helps to maintain the proper neuronal environment for synaptic signaling. This relationship has been termed the neurovascular unit (NVU). Research is now focused on understanding the cellular and molecular basis of the neurovascular unit and how diabetes alters the normal cellular communications and disrupts the cellular environment contributing to loss of vision in diabetes.

Entities:  

Keywords:  Blood-Retinal Barrier; Diabetes; Neurovascular Unit; Retina

Mesh:

Year:  2021        PMID: 33455601      PMCID: PMC8118389          DOI: 10.1017/S0952523820000115

Source DB:  PubMed          Journal:  Vis Neurosci        ISSN: 0952-5238            Impact factor:   3.241


  28 in total

1.  Nrf2 in ischemic neurons promotes retinal vascular regeneration through regulation of semaphorin 6A.

Authors:  Yanhong Wei; Junsong Gong; Zhenhua Xu; Rajesh K Thimmulappa; Katherine L Mitchell; Derek S Welsbie; Shyam Biswal; Elia J Duh
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

Review 2.  An integrated approach to diabetic retinopathy research.

Authors:  Thomas W Gardner; Steven F Abcouwer; Alistair J Barber; Gregory R Jackson
Journal:  Arch Ophthalmol       Date:  2011-02

3.  Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

Authors:  A J Barber; E Lieth; S A Khin; D A Antonetti; A G Buchanan; T W Gardner
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

4.  Neuron-derived semaphorin 3A is an early inducer of vascular permeability in diabetic retinopathy via neuropilin-1.

Authors:  Agustin Cerani; Nicolas Tetreault; Catherine Menard; Eric Lapalme; Chintan Patel; Nicholas Sitaras; Felix Beaudoin; Dominique Leboeuf; Vincent De Guire; François Binet; Agnieszka Dejda; Flavio A Rezende; Khalil Miloudi; Przemyslaw Sapieha
Journal:  Cell Metab       Date:  2013-10-01       Impact factor: 27.287

5.  The 14-year incidence of visual loss in a diabetic population.

Authors:  S E Moss; R Klein; B E Klein
Journal:  Ophthalmology       Date:  1998-06       Impact factor: 12.079

6.  Norrin/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity.

Authors:  Yanshu Wang; Amir Rattner; Yulian Zhou; John Williams; Philip M Smallwood; Jeremy Nathans
Journal:  Cell       Date:  2012-12-07       Impact factor: 41.582

7.  Canonical WNT signaling components in vascular development and barrier formation.

Authors:  Yulian Zhou; Yanshu Wang; Max Tischfield; John Williams; Philip M Smallwood; Amir Rattner; Makoto M Taketo; Jeremy Nathans
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

8.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes.

Authors:  R Klein; B E Klein; S E Moss; K J Cruickshanks
Journal:  Ophthalmology       Date:  1998-10       Impact factor: 12.079

Review 9.  Global prevalence and major risk factors of diabetic retinopathy.

Authors:  Joanne W Y Yau; Sophie L Rogers; Ryo Kawasaki; Ecosse L Lamoureux; Jonathan W Kowalski; Toke Bek; Shih-Jen Chen; Jacqueline M Dekker; Astrid Fletcher; Jakob Grauslund; Steven Haffner; Richard F Hamman; M Kamran Ikram; Takamasa Kayama; Barbara E K Klein; Ronald Klein; Sannapaneni Krishnaiah; Korapat Mayurasakorn; Joseph P O'Hare; Trevor J Orchard; Massimo Porta; Mohan Rema; Monique S Roy; Tarun Sharma; Jonathan Shaw; Hugh Taylor; James M Tielsch; Rohit Varma; Jie Jin Wang; Ningli Wang; Sheila West; Liang Xu; Miho Yasuda; Xinzhi Zhang; Paul Mitchell; Tien Y Wong
Journal:  Diabetes Care       Date:  2012-02-01       Impact factor: 19.112

10.  Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia.

Authors:  C Greene; J Kealy; M M Humphries; Y Gong; J Hou; N Hudson; L M Cassidy; R Martiniano; V Shashi; S R Hooper; G A Grant; P F Kenna; K Norris; C K Callaghan; M dN Islam; S M O'Mara; Z Najda; S G Campbell; J S Pachter; J Thomas; N M Williams; P Humphries; K C Murphy; M Campbell
Journal:  Mol Psychiatry       Date:  2017-10-10       Impact factor: 15.992

View more
  3 in total

Review 1.  The Protective Effects of Neurotrophins and MicroRNA in Diabetic Retinopathy, Nephropathy and Heart Failure via Regulating Endothelial Function.

Authors:  Sergey Shityakov; Michiaki Nagai; Süleyman Ergün; Barbara M Braunger; Carola Y Förster
Journal:  Biomolecules       Date:  2022-08-12

2.  Müller glia-derived exosomal miR-9-3p promotes angiogenesis by restricting sphingosine-1-phosphate receptor S1P1 in diabetic retinopathy.

Authors:  Yu Liu; Qin Yang; Haixin Fu; Jingfan Wang; Songtao Yuan; Xinsheng Li; Ping Xie; Zizhong Hu; Qinghuai Liu
Journal:  Mol Ther Nucleic Acids       Date:  2021-12-17       Impact factor: 8.886

Review 3.  Integrative Biology of Diabetic Retinal Disease: Lessons from Diabetic Kidney Disease.

Authors:  Warren W Pan; Thomas W Gardner; Jennifer L Harder
Journal:  J Clin Med       Date:  2021-03-18       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.